nodes	percent_of_prediction	percent_of_DWPC	metapath
Pilocarpine—CYP2E1—liver cancer	0.759	1	CbGaD
Pilocarpine—Hiccups—Epirubicin—liver cancer	0.000685	0.00371	CcSEcCtD
Pilocarpine—Vaginal inflammation—Epirubicin—liver cancer	0.000685	0.00371	CcSEcCtD
Pilocarpine—Dermatitis contact—Epirubicin—liver cancer	0.000677	0.00366	CcSEcCtD
Pilocarpine—Abnormal dreams—Epirubicin—liver cancer	0.000677	0.00366	CcSEcCtD
Pilocarpine—Eructation—Epirubicin—liver cancer	0.000673	0.00364	CcSEcCtD
Pilocarpine—Melaena—Epirubicin—liver cancer	0.000669	0.00362	CcSEcCtD
Pilocarpine—Salivary hypersecretion—Epirubicin—liver cancer	0.000665	0.0036	CcSEcCtD
Pilocarpine—Colitis—Epirubicin—liver cancer	0.000658	0.00356	CcSEcCtD
Pilocarpine—Infection—Sorafenib—liver cancer	0.000657	0.00356	CcSEcCtD
Pilocarpine—Candida infection—Epirubicin—liver cancer	0.000654	0.00354	CcSEcCtD
Pilocarpine—Atrioventricular block—Doxorubicin—liver cancer	0.000653	0.00354	CcSEcCtD
Pilocarpine—Shock—Sorafenib—liver cancer	0.000651	0.00352	CcSEcCtD
Pilocarpine—Thrombocytopenia—Sorafenib—liver cancer	0.000647	0.0035	CcSEcCtD
Pilocarpine—Vaginal infection—Epirubicin—liver cancer	0.000647	0.0035	CcSEcCtD
Pilocarpine—Neck pain—Doxorubicin—liver cancer	0.000642	0.00347	CcSEcCtD
Pilocarpine—Hiccups—Doxorubicin—liver cancer	0.000634	0.00343	CcSEcCtD
Pilocarpine—Vaginal inflammation—Doxorubicin—liver cancer	0.000634	0.00343	CcSEcCtD
Pilocarpine—Dry eye—Epirubicin—liver cancer	0.000633	0.00342	CcSEcCtD
Pilocarpine—Anorexia—Sorafenib—liver cancer	0.00063	0.00341	CcSEcCtD
Pilocarpine—Cramps of lower extremities—Epirubicin—liver cancer	0.000629	0.00341	CcSEcCtD
Pilocarpine—Dermatitis contact—Doxorubicin—liver cancer	0.000626	0.00339	CcSEcCtD
Pilocarpine—Abnormal dreams—Doxorubicin—liver cancer	0.000626	0.00339	CcSEcCtD
Pilocarpine—Oesophagitis—Epirubicin—liver cancer	0.000626	0.00339	CcSEcCtD
Pilocarpine—Eructation—Doxorubicin—liver cancer	0.000623	0.00337	CcSEcCtD
Pilocarpine—Melaena—Doxorubicin—liver cancer	0.000619	0.00335	CcSEcCtD
Pilocarpine—Salivary hypersecretion—Doxorubicin—liver cancer	0.000616	0.00333	CcSEcCtD
Pilocarpine—Pulmonary oedema—Epirubicin—liver cancer	0.00061	0.0033	CcSEcCtD
Pilocarpine—Colitis—Doxorubicin—liver cancer	0.000609	0.00329	CcSEcCtD
Pilocarpine—Candida infection—Doxorubicin—liver cancer	0.000605	0.00328	CcSEcCtD
Pilocarpine—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000602	0.00326	CcSEcCtD
Pilocarpine—Vaginal infection—Doxorubicin—liver cancer	0.000598	0.00324	CcSEcCtD
Pilocarpine—Abnormal vision—Epirubicin—liver cancer	0.000597	0.00323	CcSEcCtD
Pilocarpine—Mental disability—Epirubicin—liver cancer	0.000594	0.00322	CcSEcCtD
Pilocarpine—Dyspnoea—Sorafenib—liver cancer	0.00059	0.00319	CcSEcCtD
Pilocarpine—Dry eye—Doxorubicin—liver cancer	0.000585	0.00317	CcSEcCtD
Pilocarpine—Lymphadenopathy—Epirubicin—liver cancer	0.000583	0.00315	CcSEcCtD
Pilocarpine—Cramps of lower extremities—Doxorubicin—liver cancer	0.000582	0.00315	CcSEcCtD
Pilocarpine—Dyspepsia—Sorafenib—liver cancer	0.000582	0.00315	CcSEcCtD
Pilocarpine—Oesophagitis—Doxorubicin—liver cancer	0.000579	0.00314	CcSEcCtD
Pilocarpine—Decreased appetite—Sorafenib—liver cancer	0.000575	0.00311	CcSEcCtD
Pilocarpine—Gastrointestinal disorder—Sorafenib—liver cancer	0.000571	0.00309	CcSEcCtD
Pilocarpine—Constipation—Sorafenib—liver cancer	0.000566	0.00306	CcSEcCtD
Pilocarpine—Pain—Sorafenib—liver cancer	0.000566	0.00306	CcSEcCtD
Pilocarpine—Pulmonary oedema—Doxorubicin—liver cancer	0.000564	0.00305	CcSEcCtD
Pilocarpine—Eczema—Epirubicin—liver cancer	0.000553	0.003	CcSEcCtD
Pilocarpine—Abnormal vision—Doxorubicin—liver cancer	0.000553	0.00299	CcSEcCtD
Pilocarpine—Eye pain—Epirubicin—liver cancer	0.000551	0.00298	CcSEcCtD
Pilocarpine—Mental disability—Doxorubicin—liver cancer	0.00055	0.00298	CcSEcCtD
Pilocarpine—Gastrointestinal pain—Sorafenib—liver cancer	0.000541	0.00293	CcSEcCtD
Pilocarpine—Lymphadenopathy—Doxorubicin—liver cancer	0.000539	0.00292	CcSEcCtD
Pilocarpine—Increased appetite—Epirubicin—liver cancer	0.000529	0.00286	CcSEcCtD
Pilocarpine—Dermatitis exfoliative—Epirubicin—liver cancer	0.000527	0.00285	CcSEcCtD
Pilocarpine—Abdominal pain—Sorafenib—liver cancer	0.000523	0.00283	CcSEcCtD
Pilocarpine—Body temperature increased—Sorafenib—liver cancer	0.000523	0.00283	CcSEcCtD
Pilocarpine—Dermatitis bullous—Epirubicin—liver cancer	0.00052	0.00282	CcSEcCtD
Pilocarpine—Eczema—Doxorubicin—liver cancer	0.000512	0.00277	CcSEcCtD
Pilocarpine—Eye pain—Doxorubicin—liver cancer	0.00051	0.00276	CcSEcCtD
Pilocarpine—Hypoglycaemia—Epirubicin—liver cancer	0.00051	0.00276	CcSEcCtD
Pilocarpine—Increased appetite—Doxorubicin—liver cancer	0.00049	0.00265	CcSEcCtD
Pilocarpine—Migraine—Epirubicin—liver cancer	0.000489	0.00265	CcSEcCtD
Pilocarpine—Affect lability—Epirubicin—liver cancer	0.000489	0.00265	CcSEcCtD
Pilocarpine—Dermatitis exfoliative—Doxorubicin—liver cancer	0.000488	0.00264	CcSEcCtD
Pilocarpine—Hypersensitivity—Sorafenib—liver cancer	0.000487	0.00264	CcSEcCtD
Pilocarpine—Dermatitis bullous—Doxorubicin—liver cancer	0.000481	0.00261	CcSEcCtD
Pilocarpine—Face oedema—Epirubicin—liver cancer	0.00048	0.0026	CcSEcCtD
Pilocarpine—Asthenia—Sorafenib—liver cancer	0.000474	0.00257	CcSEcCtD
Pilocarpine—Hypoglycaemia—Doxorubicin—liver cancer	0.000471	0.00255	CcSEcCtD
Pilocarpine—Mood swings—Epirubicin—liver cancer	0.000471	0.00255	CcSEcCtD
Pilocarpine—Pruritus—Sorafenib—liver cancer	0.000468	0.00253	CcSEcCtD
Pilocarpine—Liver function test abnormal—Epirubicin—liver cancer	0.000459	0.00249	CcSEcCtD
Pilocarpine—Dry skin—Epirubicin—liver cancer	0.000456	0.00247	CcSEcCtD
Pilocarpine—Migraine—Doxorubicin—liver cancer	0.000453	0.00245	CcSEcCtD
Pilocarpine—Affect lability—Doxorubicin—liver cancer	0.000453	0.00245	CcSEcCtD
Pilocarpine—Diarrhoea—Sorafenib—liver cancer	0.000452	0.00245	CcSEcCtD
Pilocarpine—Face oedema—Doxorubicin—liver cancer	0.000444	0.0024	CcSEcCtD
Pilocarpine—Gastritis—Epirubicin—liver cancer	0.00044	0.00238	CcSEcCtD
Pilocarpine—Muscular weakness—Epirubicin—liver cancer	0.000439	0.00237	CcSEcCtD
Pilocarpine—Dizziness—Sorafenib—liver cancer	0.000437	0.00237	CcSEcCtD
Pilocarpine—Mood swings—Doxorubicin—liver cancer	0.000436	0.00236	CcSEcCtD
Pilocarpine—Dysphagia—Epirubicin—liver cancer	0.00043	0.00233	CcSEcCtD
Pilocarpine—Influenza—Epirubicin—liver cancer	0.00043	0.00233	CcSEcCtD
Pilocarpine—Liver function test abnormal—Doxorubicin—liver cancer	0.000425	0.0023	CcSEcCtD
Pilocarpine—Dry skin—Doxorubicin—liver cancer	0.000422	0.00228	CcSEcCtD
Pilocarpine—Pancreatitis—Epirubicin—liver cancer	0.000421	0.00228	CcSEcCtD
Pilocarpine—Vomiting—Sorafenib—liver cancer	0.00042	0.00228	CcSEcCtD
Pilocarpine—Angina pectoris—Epirubicin—liver cancer	0.000419	0.00227	CcSEcCtD
Pilocarpine—Rash—Sorafenib—liver cancer	0.000417	0.00226	CcSEcCtD
Pilocarpine—Dermatitis—Sorafenib—liver cancer	0.000417	0.00225	CcSEcCtD
Pilocarpine—Headache—Sorafenib—liver cancer	0.000414	0.00224	CcSEcCtD
Pilocarpine—Bronchitis—Epirubicin—liver cancer	0.000413	0.00224	CcSEcCtD
Pilocarpine—Gastritis—Doxorubicin—liver cancer	0.000407	0.0022	CcSEcCtD
Pilocarpine—Muscular weakness—Doxorubicin—liver cancer	0.000406	0.0022	CcSEcCtD
Pilocarpine—Dysuria—Epirubicin—liver cancer	0.000402	0.00218	CcSEcCtD
Pilocarpine—Influenza—Doxorubicin—liver cancer	0.000398	0.00215	CcSEcCtD
Pilocarpine—Dysphagia—Doxorubicin—liver cancer	0.000398	0.00215	CcSEcCtD
Pilocarpine—Pollakiuria—Epirubicin—liver cancer	0.000397	0.00215	CcSEcCtD
Pilocarpine—Nausea—Sorafenib—liver cancer	0.000393	0.00213	CcSEcCtD
Pilocarpine—Photosensitivity reaction—Epirubicin—liver cancer	0.000392	0.00212	CcSEcCtD
Pilocarpine—Pancreatitis—Doxorubicin—liver cancer	0.00039	0.00211	CcSEcCtD
Pilocarpine—Angina pectoris—Doxorubicin—liver cancer	0.000387	0.0021	CcSEcCtD
Pilocarpine—Pneumonia—Epirubicin—liver cancer	0.000385	0.00209	CcSEcCtD
Pilocarpine—Bronchitis—Doxorubicin—liver cancer	0.000382	0.00207	CcSEcCtD
Pilocarpine—Stomatitis—Epirubicin—liver cancer	0.000374	0.00202	CcSEcCtD
Pilocarpine—Urinary tract infection—Epirubicin—liver cancer	0.000372	0.00202	CcSEcCtD
Pilocarpine—Conjunctivitis—Epirubicin—liver cancer	0.000372	0.00202	CcSEcCtD
Pilocarpine—Dysuria—Doxorubicin—liver cancer	0.000372	0.00201	CcSEcCtD
Pilocarpine—Sweating—Epirubicin—liver cancer	0.000367	0.00199	CcSEcCtD
Pilocarpine—Pollakiuria—Doxorubicin—liver cancer	0.000367	0.00199	CcSEcCtD
Pilocarpine—Haematuria—Epirubicin—liver cancer	0.000365	0.00198	CcSEcCtD
Pilocarpine—Photosensitivity reaction—Doxorubicin—liver cancer	0.000363	0.00196	CcSEcCtD
Pilocarpine—Epistaxis—Epirubicin—liver cancer	0.000361	0.00196	CcSEcCtD
Pilocarpine—Sinusitis—Epirubicin—liver cancer	0.00036	0.00195	CcSEcCtD
Pilocarpine—Pneumonia—Doxorubicin—liver cancer	0.000357	0.00193	CcSEcCtD
Pilocarpine—Bradycardia—Epirubicin—liver cancer	0.00035	0.0019	CcSEcCtD
Pilocarpine—Stomatitis—Doxorubicin—liver cancer	0.000346	0.00187	CcSEcCtD
Pilocarpine—Rhinitis—Epirubicin—liver cancer	0.000345	0.00187	CcSEcCtD
Pilocarpine—Urinary tract infection—Doxorubicin—liver cancer	0.000345	0.00187	CcSEcCtD
Pilocarpine—Conjunctivitis—Doxorubicin—liver cancer	0.000345	0.00187	CcSEcCtD
Pilocarpine—Hepatitis—Epirubicin—liver cancer	0.000344	0.00186	CcSEcCtD
Pilocarpine—Hypoaesthesia—Epirubicin—liver cancer	0.000342	0.00185	CcSEcCtD
Pilocarpine—Pharyngitis—Epirubicin—liver cancer	0.000341	0.00185	CcSEcCtD
Pilocarpine—Sweating—Doxorubicin—liver cancer	0.00034	0.00184	CcSEcCtD
Pilocarpine—Oedema peripheral—Epirubicin—liver cancer	0.000339	0.00183	CcSEcCtD
Pilocarpine—Haematuria—Doxorubicin—liver cancer	0.000338	0.00183	CcSEcCtD
Pilocarpine—Epistaxis—Doxorubicin—liver cancer	0.000334	0.00181	CcSEcCtD
Pilocarpine—Sinusitis—Doxorubicin—liver cancer	0.000333	0.0018	CcSEcCtD
Pilocarpine—Visual impairment—Epirubicin—liver cancer	0.000332	0.00179	CcSEcCtD
Pilocarpine—Bradycardia—Doxorubicin—liver cancer	0.000324	0.00175	CcSEcCtD
Pilocarpine—Eye disorder—Epirubicin—liver cancer	0.000321	0.00174	CcSEcCtD
Pilocarpine—Tinnitus—Epirubicin—liver cancer	0.000321	0.00174	CcSEcCtD
Pilocarpine—Flushing—Epirubicin—liver cancer	0.000319	0.00173	CcSEcCtD
Pilocarpine—Rhinitis—Doxorubicin—liver cancer	0.000319	0.00173	CcSEcCtD
Pilocarpine—Hepatitis—Doxorubicin—liver cancer	0.000318	0.00172	CcSEcCtD
Pilocarpine—Hypoaesthesia—Doxorubicin—liver cancer	0.000317	0.00171	CcSEcCtD
Pilocarpine—Pharyngitis—Doxorubicin—liver cancer	0.000316	0.00171	CcSEcCtD
Pilocarpine—Oedema peripheral—Doxorubicin—liver cancer	0.000314	0.0017	CcSEcCtD
Pilocarpine—Chills—Epirubicin—liver cancer	0.000309	0.00167	CcSEcCtD
Pilocarpine—Arrhythmia—Epirubicin—liver cancer	0.000307	0.00166	CcSEcCtD
Pilocarpine—Visual impairment—Doxorubicin—liver cancer	0.000307	0.00166	CcSEcCtD
Pilocarpine—Alopecia—Epirubicin—liver cancer	0.000304	0.00165	CcSEcCtD
Pilocarpine—Eye disorder—Doxorubicin—liver cancer	0.000297	0.00161	CcSEcCtD
Pilocarpine—Tinnitus—Doxorubicin—liver cancer	0.000297	0.00161	CcSEcCtD
Pilocarpine—Flushing—Doxorubicin—liver cancer	0.000295	0.0016	CcSEcCtD
Pilocarpine—Flatulence—Epirubicin—liver cancer	0.000295	0.0016	CcSEcCtD
Pilocarpine—Tension—Epirubicin—liver cancer	0.000294	0.00159	CcSEcCtD
Pilocarpine—Dysgeusia—Epirubicin—liver cancer	0.000293	0.00159	CcSEcCtD
Pilocarpine—Nervousness—Epirubicin—liver cancer	0.000291	0.00157	CcSEcCtD
Pilocarpine—Back pain—Epirubicin—liver cancer	0.00029	0.00157	CcSEcCtD
Pilocarpine—Muscle spasms—Epirubicin—liver cancer	0.000288	0.00156	CcSEcCtD
Pilocarpine—Chills—Doxorubicin—liver cancer	0.000286	0.00155	CcSEcCtD
Pilocarpine—Arrhythmia—Doxorubicin—liver cancer	0.000284	0.00154	CcSEcCtD
Pilocarpine—Vision blurred—Epirubicin—liver cancer	0.000282	0.00153	CcSEcCtD
Pilocarpine—Alopecia—Doxorubicin—liver cancer	0.000281	0.00152	CcSEcCtD
Pilocarpine—Agitation—Epirubicin—liver cancer	0.000275	0.00149	CcSEcCtD
Pilocarpine—Flatulence—Doxorubicin—liver cancer	0.000273	0.00148	CcSEcCtD
Pilocarpine—Tension—Doxorubicin—liver cancer	0.000272	0.00147	CcSEcCtD
Pilocarpine—Dysgeusia—Doxorubicin—liver cancer	0.000271	0.00147	CcSEcCtD
Pilocarpine—Nervousness—Doxorubicin—liver cancer	0.000269	0.00146	CcSEcCtD
Pilocarpine—Syncope—Epirubicin—liver cancer	0.000269	0.00145	CcSEcCtD
Pilocarpine—Leukopenia—Epirubicin—liver cancer	0.000268	0.00145	CcSEcCtD
Pilocarpine—Back pain—Doxorubicin—liver cancer	0.000268	0.00145	CcSEcCtD
Pilocarpine—Muscle spasms—Doxorubicin—liver cancer	0.000266	0.00144	CcSEcCtD
Pilocarpine—Palpitations—Epirubicin—liver cancer	0.000265	0.00143	CcSEcCtD
Pilocarpine—Loss of consciousness—Epirubicin—liver cancer	0.000263	0.00142	CcSEcCtD
Pilocarpine—Cough—Epirubicin—liver cancer	0.000261	0.00141	CcSEcCtD
Pilocarpine—Vision blurred—Doxorubicin—liver cancer	0.000261	0.00141	CcSEcCtD
Pilocarpine—Hypertension—Epirubicin—liver cancer	0.000259	0.0014	CcSEcCtD
Pilocarpine—Myalgia—Epirubicin—liver cancer	0.000255	0.00138	CcSEcCtD
Pilocarpine—Arthralgia—Epirubicin—liver cancer	0.000255	0.00138	CcSEcCtD
Pilocarpine—Chest pain—Epirubicin—liver cancer	0.000255	0.00138	CcSEcCtD
Pilocarpine—Agitation—Doxorubicin—liver cancer	0.000255	0.00138	CcSEcCtD
Pilocarpine—Anxiety—Epirubicin—liver cancer	0.000254	0.00138	CcSEcCtD
Pilocarpine—Discomfort—Epirubicin—liver cancer	0.000252	0.00136	CcSEcCtD
Pilocarpine—Syncope—Doxorubicin—liver cancer	0.000248	0.00135	CcSEcCtD
Pilocarpine—Leukopenia—Doxorubicin—liver cancer	0.000248	0.00134	CcSEcCtD
Pilocarpine—Confusional state—Epirubicin—liver cancer	0.000246	0.00133	CcSEcCtD
Pilocarpine—Palpitations—Doxorubicin—liver cancer	0.000245	0.00133	CcSEcCtD
Pilocarpine—Oedema—Epirubicin—liver cancer	0.000244	0.00132	CcSEcCtD
Pilocarpine—Loss of consciousness—Doxorubicin—liver cancer	0.000244	0.00132	CcSEcCtD
Pilocarpine—Infection—Epirubicin—liver cancer	0.000243	0.00131	CcSEcCtD
Pilocarpine—Cough—Doxorubicin—liver cancer	0.000242	0.00131	CcSEcCtD
Pilocarpine—Shock—Epirubicin—liver cancer	0.00024	0.0013	CcSEcCtD
Pilocarpine—Thrombocytopenia—Epirubicin—liver cancer	0.000239	0.0013	CcSEcCtD
Pilocarpine—Hypertension—Doxorubicin—liver cancer	0.000239	0.00129	CcSEcCtD
Pilocarpine—Tachycardia—Epirubicin—liver cancer	0.000239	0.00129	CcSEcCtD
Pilocarpine—Hyperhidrosis—Epirubicin—liver cancer	0.000236	0.00128	CcSEcCtD
Pilocarpine—Chest pain—Doxorubicin—liver cancer	0.000236	0.00128	CcSEcCtD
Pilocarpine—Arthralgia—Doxorubicin—liver cancer	0.000236	0.00128	CcSEcCtD
Pilocarpine—Myalgia—Doxorubicin—liver cancer	0.000236	0.00128	CcSEcCtD
Pilocarpine—Anxiety—Doxorubicin—liver cancer	0.000235	0.00127	CcSEcCtD
Pilocarpine—Discomfort—Doxorubicin—liver cancer	0.000233	0.00126	CcSEcCtD
Pilocarpine—Anorexia—Epirubicin—liver cancer	0.000233	0.00126	CcSEcCtD
Pilocarpine—Hypotension—Epirubicin—liver cancer	0.000228	0.00124	CcSEcCtD
Pilocarpine—Confusional state—Doxorubicin—liver cancer	0.000228	0.00123	CcSEcCtD
Pilocarpine—Oedema—Doxorubicin—liver cancer	0.000226	0.00122	CcSEcCtD
Pilocarpine—Infection—Doxorubicin—liver cancer	0.000225	0.00122	CcSEcCtD
Pilocarpine—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000223	0.00121	CcSEcCtD
Pilocarpine—Shock—Doxorubicin—liver cancer	0.000222	0.0012	CcSEcCtD
Pilocarpine—Thrombocytopenia—Doxorubicin—liver cancer	0.000221	0.0012	CcSEcCtD
Pilocarpine—Insomnia—Epirubicin—liver cancer	0.000221	0.0012	CcSEcCtD
Pilocarpine—Tachycardia—Doxorubicin—liver cancer	0.000221	0.00119	CcSEcCtD
Pilocarpine—Paraesthesia—Epirubicin—liver cancer	0.000219	0.00119	CcSEcCtD
Pilocarpine—Hyperhidrosis—Doxorubicin—liver cancer	0.000219	0.00118	CcSEcCtD
Pilocarpine—Dyspnoea—Epirubicin—liver cancer	0.000218	0.00118	CcSEcCtD
Pilocarpine—Somnolence—Epirubicin—liver cancer	0.000217	0.00118	CcSEcCtD
Pilocarpine—Anorexia—Doxorubicin—liver cancer	0.000216	0.00117	CcSEcCtD
Pilocarpine—Dyspepsia—Epirubicin—liver cancer	0.000215	0.00116	CcSEcCtD
Pilocarpine—Decreased appetite—Epirubicin—liver cancer	0.000212	0.00115	CcSEcCtD
Pilocarpine—Hypotension—Doxorubicin—liver cancer	0.000211	0.00114	CcSEcCtD
Pilocarpine—Gastrointestinal disorder—Epirubicin—liver cancer	0.000211	0.00114	CcSEcCtD
Pilocarpine—Constipation—Epirubicin—liver cancer	0.000209	0.00113	CcSEcCtD
Pilocarpine—Pain—Epirubicin—liver cancer	0.000209	0.00113	CcSEcCtD
Pilocarpine—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000206	0.00112	CcSEcCtD
Pilocarpine—Insomnia—Doxorubicin—liver cancer	0.000205	0.00111	CcSEcCtD
Pilocarpine—Paraesthesia—Doxorubicin—liver cancer	0.000203	0.0011	CcSEcCtD
Pilocarpine—Dyspnoea—Doxorubicin—liver cancer	0.000202	0.00109	CcSEcCtD
Pilocarpine—Feeling abnormal—Epirubicin—liver cancer	0.000201	0.00109	CcSEcCtD
Pilocarpine—Somnolence—Doxorubicin—liver cancer	0.000201	0.00109	CcSEcCtD
Pilocarpine—Gastrointestinal pain—Epirubicin—liver cancer	0.0002	0.00108	CcSEcCtD
Pilocarpine—Dyspepsia—Doxorubicin—liver cancer	0.000199	0.00108	CcSEcCtD
Pilocarpine—Decreased appetite—Doxorubicin—liver cancer	0.000197	0.00106	CcSEcCtD
Pilocarpine—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000195	0.00106	CcSEcCtD
Pilocarpine—Constipation—Doxorubicin—liver cancer	0.000193	0.00105	CcSEcCtD
Pilocarpine—Pain—Doxorubicin—liver cancer	0.000193	0.00105	CcSEcCtD
Pilocarpine—Abdominal pain—Epirubicin—liver cancer	0.000193	0.00105	CcSEcCtD
Pilocarpine—Body temperature increased—Epirubicin—liver cancer	0.000193	0.00105	CcSEcCtD
Pilocarpine—Feeling abnormal—Doxorubicin—liver cancer	0.000186	0.00101	CcSEcCtD
Pilocarpine—Gastrointestinal pain—Doxorubicin—liver cancer	0.000185	0.001	CcSEcCtD
Pilocarpine—Hypersensitivity—Epirubicin—liver cancer	0.00018	0.000975	CcSEcCtD
Pilocarpine—Body temperature increased—Doxorubicin—liver cancer	0.000179	0.000968	CcSEcCtD
Pilocarpine—Abdominal pain—Doxorubicin—liver cancer	0.000179	0.000968	CcSEcCtD
Pilocarpine—Asthenia—Epirubicin—liver cancer	0.000175	0.000949	CcSEcCtD
Pilocarpine—Pruritus—Epirubicin—liver cancer	0.000173	0.000936	CcSEcCtD
Pilocarpine—Diarrhoea—Epirubicin—liver cancer	0.000167	0.000905	CcSEcCtD
Pilocarpine—Hypersensitivity—Doxorubicin—liver cancer	0.000167	0.000902	CcSEcCtD
Pilocarpine—Asthenia—Doxorubicin—liver cancer	0.000162	0.000878	CcSEcCtD
Pilocarpine—Dizziness—Epirubicin—liver cancer	0.000162	0.000875	CcSEcCtD
Pilocarpine—Pruritus—Doxorubicin—liver cancer	0.00016	0.000866	CcSEcCtD
Pilocarpine—Vomiting—Epirubicin—liver cancer	0.000155	0.000841	CcSEcCtD
Pilocarpine—Diarrhoea—Doxorubicin—liver cancer	0.000155	0.000838	CcSEcCtD
Pilocarpine—Rash—Epirubicin—liver cancer	0.000154	0.000834	CcSEcCtD
Pilocarpine—Dermatitis—Epirubicin—liver cancer	0.000154	0.000833	CcSEcCtD
Pilocarpine—Headache—Epirubicin—liver cancer	0.000153	0.000829	CcSEcCtD
Pilocarpine—Dizziness—Doxorubicin—liver cancer	0.00015	0.000809	CcSEcCtD
Pilocarpine—Nausea—Epirubicin—liver cancer	0.000145	0.000786	CcSEcCtD
Pilocarpine—Vomiting—Doxorubicin—liver cancer	0.000144	0.000778	CcSEcCtD
Pilocarpine—Rash—Doxorubicin—liver cancer	0.000143	0.000772	CcSEcCtD
Pilocarpine—Dermatitis—Doxorubicin—liver cancer	0.000142	0.000771	CcSEcCtD
Pilocarpine—Headache—Doxorubicin—liver cancer	0.000142	0.000767	CcSEcCtD
Pilocarpine—Nausea—Doxorubicin—liver cancer	0.000134	0.000727	CcSEcCtD
Pilocarpine—CHRM1—Signaling Pathways—ADAM17—liver cancer	2.25e-05	0.000403	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—ADAM17—liver cancer	2.25e-05	0.000402	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—ADAM17—liver cancer	2.23e-05	0.000398	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—CYCS—liver cancer	2.16e-05	0.000386	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—PSMA4—liver cancer	2.13e-05	0.000381	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—PSMD10—liver cancer	2.13e-05	0.000381	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—F2—liver cancer	2.13e-05	0.00038	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—GGT1—liver cancer	2.12e-05	0.000379	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—GOT1—liver cancer	2.12e-05	0.000379	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—PSMA4—liver cancer	2.12e-05	0.000379	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—PSMD10—liver cancer	2.12e-05	0.000379	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—F2—liver cancer	2.12e-05	0.000379	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—PSMD10—liver cancer	2.11e-05	0.000378	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—PSMA4—liver cancer	2.11e-05	0.000378	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—F2—liver cancer	2.1e-05	0.000375	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—PSMA4—liver cancer	2.09e-05	0.000374	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—PSMD10—liver cancer	2.09e-05	0.000374	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—GOT2—liver cancer	2.07e-05	0.00037	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—PIK3CG—liver cancer	2.03e-05	0.000363	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—GSTP1—liver cancer	2.03e-05	0.000363	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—PIK3CG—liver cancer	2.03e-05	0.000362	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—PIK3CG—liver cancer	2.01e-05	0.000359	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—HMOX1—liver cancer	2e-05	0.000358	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—F2—liver cancer	1.93e-05	0.000345	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—F2—liver cancer	1.92e-05	0.000344	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—GSTP1—liver cancer	1.91e-05	0.000341	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—F2—liver cancer	1.91e-05	0.00034	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—HMOX1—liver cancer	1.88e-05	0.000336	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—GSTM1—liver cancer	1.87e-05	0.000334	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—PIK3CG—liver cancer	1.85e-05	0.00033	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—PIK3CG—liver cancer	1.84e-05	0.000329	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—PIK3CG—liver cancer	1.82e-05	0.000326	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—CYCS—liver cancer	1.82e-05	0.000326	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—GGT1—liver cancer	1.79e-05	0.00032	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—GOT1—liver cancer	1.79e-05	0.00032	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—PIK3CD—liver cancer	1.79e-05	0.00032	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—PIK3CD—liver cancer	1.78e-05	0.000318	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—CYP1A1—liver cancer	1.77e-05	0.000316	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—PIK3CD—liver cancer	1.76e-05	0.000315	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—GSTM1—liver cancer	1.75e-05	0.000313	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CPT1B—liver cancer	1.72e-05	0.000307	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—GLUL—liver cancer	1.72e-05	0.000307	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—CYP1A1—liver cancer	1.66e-05	0.000297	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—NR1H4—liver cancer	1.66e-05	0.000296	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—MTHFR—liver cancer	1.65e-05	0.000295	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—PRKCE—liver cancer	1.64e-05	0.000293	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—PRKCE—liver cancer	1.64e-05	0.000293	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—GSTA3—liver cancer	1.63e-05	0.000291	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—PIK3CD—liver cancer	1.62e-05	0.00029	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—PRKCE—liver cancer	1.62e-05	0.00029	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—PPARA—liver cancer	1.62e-05	0.000289	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—PIK3CD—liver cancer	1.62e-05	0.000289	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—GSTP1—liver cancer	1.61e-05	0.000287	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—PIK3CD—liver cancer	1.6e-05	0.000286	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—HMOX1—liver cancer	1.58e-05	0.000283	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—PIK3CB—liver cancer	1.56e-05	0.000278	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—IGF2—liver cancer	1.56e-05	0.000278	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—PIK3CB—liver cancer	1.55e-05	0.000278	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—IGF2—liver cancer	1.55e-05	0.000277	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—MTHFR—liver cancer	1.55e-05	0.000277	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—PIK3CB—liver cancer	1.54e-05	0.000275	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—IGF2—liver cancer	1.54e-05	0.000274	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—PPARA—liver cancer	1.52e-05	0.000271	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—GSTA4—liver cancer	1.49e-05	0.000267	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—GSTM1—liver cancer	1.48e-05	0.000264	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—GSTA2—liver cancer	1.45e-05	0.00026	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CSF2—liver cancer	1.45e-05	0.00026	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—RAF1—liver cancer	1.45e-05	0.000259	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CSF2—liver cancer	1.45e-05	0.000259	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—RAF1—liver cancer	1.44e-05	0.000258	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CSF2—liver cancer	1.43e-05	0.000256	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—H2AFX—liver cancer	1.43e-05	0.000256	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—IL2—liver cancer	1.43e-05	0.000256	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—RAF1—liver cancer	1.43e-05	0.000256	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—H2AFX—liver cancer	1.43e-05	0.000255	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—IL2—liver cancer	1.43e-05	0.000255	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—PIK3CB—liver cancer	1.42e-05	0.000253	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—H2AFX—liver cancer	1.41e-05	0.000253	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—IL2—liver cancer	1.41e-05	0.000252	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—PIK3CB—liver cancer	1.41e-05	0.000252	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—GSTA1—liver cancer	1.4e-05	0.000251	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—CYP1A1—liver cancer	1.4e-05	0.00025	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—PIK3CB—liver cancer	1.4e-05	0.00025	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—PIK3CG—liver cancer	1.39e-05	0.000248	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—NAT2—liver cancer	1.39e-05	0.000248	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—PPARG—liver cancer	1.34e-05	0.000239	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—ALDOB—liver cancer	1.33e-05	0.000238	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—MTHFR—liver cancer	1.3e-05	0.000233	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—PIK3CG—liver cancer	1.3e-05	0.000232	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—IL2—liver cancer	1.3e-05	0.000232	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—IL2—liver cancer	1.3e-05	0.000232	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—TERT—liver cancer	1.29e-05	0.000231	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—TERT—liver cancer	1.29e-05	0.000231	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—IL2—liver cancer	1.28e-05	0.000229	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—PPARA—liver cancer	1.28e-05	0.000229	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—TERT—liver cancer	1.28e-05	0.000228	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CRABP1—liver cancer	1.27e-05	0.000227	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—PPARG—liver cancer	1.26e-05	0.000224	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—PIK3CD—liver cancer	1.22e-05	0.000218	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—ALB—liver cancer	1.2e-05	0.000215	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—KDR—liver cancer	1.18e-05	0.000212	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—KDR—liver cancer	1.18e-05	0.000211	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—MAPK14—liver cancer	1.18e-05	0.00021	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—MAPK14—liver cancer	1.17e-05	0.00021	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—KDR—liver cancer	1.17e-05	0.000209	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—MAPK14—liver cancer	1.16e-05	0.000208	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—ESR1—liver cancer	1.15e-05	0.000206	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—ESR1—liver cancer	1.15e-05	0.000206	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—PIK3CD—liver cancer	1.14e-05	0.000204	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—F2—liver cancer	1.14e-05	0.000204	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—ESR1—liver cancer	1.14e-05	0.000204	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—F2—liver cancer	1.14e-05	0.000203	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—ALB—liver cancer	1.13e-05	0.000202	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—F2—liver cancer	1.13e-05	0.000201	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—HPGDS—liver cancer	1.11e-05	0.000198	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—PIK3CG—liver cancer	1.1e-05	0.000196	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—APC—liver cancer	1.09e-05	0.000195	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—PIK3CG—liver cancer	1.09e-05	0.000195	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—APC—liver cancer	1.09e-05	0.000194	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—PIK3CG—liver cancer	1.09e-05	0.000194	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—PIK3CG—liver cancer	1.08e-05	0.000192	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—APC—liver cancer	1.08e-05	0.000192	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—PIK3CB—liver cancer	1.06e-05	0.00019	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—PPARG—liver cancer	1.06e-05	0.000189	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—BRAF—liver cancer	1.03e-05	0.000183	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—BRAF—liver cancer	1.02e-05	0.000183	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—BRAF—liver cancer	1.01e-05	0.000181	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—PIK3CB—liver cancer	9.97e-06	0.000178	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PSMA4—liver cancer	9.88e-06	0.000177	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PSMD10—liver cancer	9.88e-06	0.000177	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—PIK3CD—liver cancer	9.63e-06	0.000172	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—GOT2—liver cancer	9.61e-06	0.000172	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—PIK3CD—liver cancer	9.59e-06	0.000171	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—PIK3CD—liver cancer	9.56e-06	0.000171	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—ALB—liver cancer	9.51e-06	0.00017	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—PIK3CA—liver cancer	9.5e-06	0.00017	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—SERPINE1—liver cancer	9.49e-06	0.00017	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—PIK3CA—liver cancer	9.47e-06	0.000169	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—PIK3CD—liver cancer	9.47e-06	0.000169	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—SERPINE1—liver cancer	9.46e-06	0.000169	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—KRAS—liver cancer	9.39e-06	0.000168	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—PIK3CA—liver cancer	9.38e-06	0.000168	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—SERPINE1—liver cancer	9.36e-06	0.000167	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—KRAS—liver cancer	9.36e-06	0.000167	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—KRAS—liver cancer	9.27e-06	0.000166	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CYP2E1—liver cancer	9.04e-06	0.000161	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—PIK3CA—liver cancer	8.63e-06	0.000154	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—PIK3CA—liver cancer	8.6e-06	0.000154	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—RAF1—liver cancer	8.56e-06	0.000153	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—RAF1—liver cancer	8.54e-06	0.000153	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—PIK3CA—liver cancer	8.52e-06	0.000152	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CYCS—liver cancer	8.45e-06	0.000151	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—RAF1—liver cancer	8.45e-06	0.000151	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—PIK3CB—liver cancer	8.4e-06	0.00015	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—PIK3CB—liver cancer	8.36e-06	0.000149	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—MTOR—liver cancer	8.36e-06	0.000149	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—PIK3CB—liver cancer	8.33e-06	0.000149	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—MTOR—liver cancer	8.33e-06	0.000149	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—GGT1—liver cancer	8.3e-06	0.000148	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—GOT1—liver cancer	8.3e-06	0.000148	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—MTOR—liver cancer	8.25e-06	0.000147	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—PIK3CB—liver cancer	8.25e-06	0.000147	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—HRAS—liver cancer	7.98e-06	0.000143	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—HRAS—liver cancer	7.96e-06	0.000142	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—HRAS—liver cancer	7.88e-06	0.000141	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CDKN1B—liver cancer	7.85e-06	0.00014	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CDKN1B—liver cancer	7.82e-06	0.00014	CbGpPWpGaD
Pilocarpine—CHRM1—GPCR downstream signaling—AKT1—liver cancer	7.76e-06	0.000139	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CDKN1B—liver cancer	7.74e-06	0.000138	CbGpPWpGaD
Pilocarpine—CHRM3—GPCR downstream signaling—AKT1—liver cancer	7.74e-06	0.000138	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CASP3—liver cancer	7.69e-06	0.000137	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—IL2—liver cancer	7.68e-06	0.000137	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CASP3—liver cancer	7.66e-06	0.000137	CbGpPWpGaD
Pilocarpine—CHRM2—GPCR downstream signaling—AKT1—liver cancer	7.66e-06	0.000137	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—IL2—liver cancer	7.65e-06	0.000137	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—IL6—liver cancer	7.64e-06	0.000137	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—IL6—liver cancer	7.62e-06	0.000136	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CASP3—liver cancer	7.59e-06	0.000136	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—IL2—liver cancer	7.58e-06	0.000135	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—IL6—liver cancer	7.54e-06	0.000135	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CCND1—liver cancer	7.48e-06	0.000134	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—JUN—liver cancer	7.47e-06	0.000133	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CCND1—liver cancer	7.46e-06	0.000133	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—GSTP1—liver cancer	7.45e-06	0.000133	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—JUN—liver cancer	7.45e-06	0.000133	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CTNNB1—liver cancer	7.41e-06	0.000132	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CCND1—liver cancer	7.39e-06	0.000132	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CTNNB1—liver cancer	7.39e-06	0.000132	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—JUN—liver cancer	7.37e-06	0.000132	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—HMOX1—liver cancer	7.35e-06	0.000131	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CTNNB1—liver cancer	7.32e-06	0.000131	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—MMP9—liver cancer	7.27e-06	0.00013	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—MMP9—liver cancer	7.24e-06	0.000129	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—CDKN1A—liver cancer	7.24e-06	0.000129	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—CDKN1A—liver cancer	7.22e-06	0.000129	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—MMP9—liver cancer	7.17e-06	0.000128	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—CDKN1A—liver cancer	7.15e-06	0.000128	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—MAPK8—liver cancer	7.07e-06	0.000126	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling by GPCR—AKT1—liver cancer	7.05e-06	0.000126	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—MAPK8—liver cancer	7.04e-06	0.000126	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling by GPCR—AKT1—liver cancer	7.03e-06	0.000126	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—MAPK8—liver cancer	6.98e-06	0.000125	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling by GPCR—AKT1—liver cancer	6.96e-06	0.000124	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—GSTM1—liver cancer	6.85e-06	0.000122	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—VEGFA—liver cancer	6.53e-06	0.000117	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—VEGFA—liver cancer	6.5e-06	0.000116	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—CYP1A1—liver cancer	6.49e-06	0.000116	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—PIK3CA—liver cancer	6.48e-06	0.000116	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—STAT3—liver cancer	6.46e-06	0.000115	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—VEGFA—liver cancer	6.44e-06	0.000115	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—STAT3—liver cancer	6.44e-06	0.000115	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—STAT3—liver cancer	6.38e-06	0.000114	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—PIK3CA—liver cancer	6.08e-06	0.000109	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—MTHFR—liver cancer	6.05e-06	0.000108	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—MYC—liver cancer	6e-06	0.000107	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—TGFB1—liver cancer	5.99e-06	0.000107	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—MYC—liver cancer	5.98e-06	0.000107	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—TGFB1—liver cancer	5.97e-06	0.000107	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PPARA—liver cancer	5.94e-06	0.000106	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—MYC—liver cancer	5.93e-06	0.000106	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—TGFB1—liver cancer	5.91e-06	0.000106	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—KRAS—liver cancer	5.55e-06	9.91e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—KRAS—liver cancer	5.53e-06	9.88e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—KRAS—liver cancer	5.48e-06	9.79e-05	CbGpPWpGaD
Pilocarpine—CYP2A6—Metabolism—AKT1—liver cancer	5.29e-06	9.46e-05	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—PIK3CA—liver cancer	5.12e-06	9.15e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—PIK3CA—liver cancer	5.1e-06	9.11e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PIK3CG—liver cancer	5.08e-06	9.09e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—PIK3CA—liver cancer	5.08e-06	9.08e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—PIK3CA—liver cancer	5.03e-06	8.99e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Metabolism—AKT1—liver cancer	4.96e-06	8.87e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—TP53—liver cancer	4.93e-06	8.81e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—TP53—liver cancer	4.91e-06	8.78e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PPARG—liver cancer	4.91e-06	8.77e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—TP53—liver cancer	4.87e-06	8.7e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—HRAS—liver cancer	4.72e-06	8.43e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—HRAS—liver cancer	4.7e-06	8.4e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—HRAS—liver cancer	4.65e-06	8.32e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—IL6—liver cancer	4.51e-06	8.06e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—IL6—liver cancer	4.5e-06	8.04e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PIK3CD—liver cancer	4.47e-06	7.99e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—IL6—liver cancer	4.45e-06	7.96e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—ALB—liver cancer	4.41e-06	7.89e-05	CbGpPWpGaD
Pilocarpine—CYP2E1—Metabolism—AKT1—liver cancer	4.18e-06	7.47e-05	CbGpPWpGaD
Pilocarpine—CHRM1—Signaling Pathways—AKT1—liver cancer	4.16e-06	7.44e-05	CbGpPWpGaD
Pilocarpine—CHRM3—Signaling Pathways—AKT1—liver cancer	4.15e-06	7.42e-05	CbGpPWpGaD
Pilocarpine—CHRM2—Signaling Pathways—AKT1—liver cancer	4.11e-06	7.34e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PIK3CB—liver cancer	3.9e-06	6.96e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—PIK3CA—liver cancer	2.38e-06	4.24e-05	CbGpPWpGaD
Pilocarpine—CYP3A4—Metabolism—AKT1—liver cancer	1.94e-06	3.47e-05	CbGpPWpGaD
